期刊文献+

人sFlt-1基因转染骨髓基质细胞对K562细胞生长的影响

Effect of bone marrow stromal cells transfeted by human sFlt-1 gene on growth of K562 cells
下载PDF
导出
摘要 目的:通过转基因的方法获得人可溶性血管内皮生长因子受体1(sFlt-1)蛋白的稳定表达,并检测其对K562细胞生长的影响。方法:构建真核表达载体pcDNA3-sFlt-1D4,用脂质体介导的方法将其转染骨髓基质细胞,采用RT-PCR、ELISA和MTT法检测转基因产物的表达及对K562细胞生长的影响。结果:流式细胞仪检测骨髓基质细胞的转染率为9.27%。ELISA法检测转染后24h、48h及4周转基因骨髓基质细胞培养上清中sFlt-1D4蛋白的表达浓度分别为(0.104±0.078)、(0.158±0.022)和(0.171±0.069)μg.L-1。ELISA法证实转基因组培养上清中VEGF含量降低。MTT法检测转染24h、48h及4周的转基因产物对K562细胞的抑瘤率分别为9.41%±4.71%、23.63%±7.50%和33.13%±6.93%。结论:转基因方法可以获得sFlt-1D4蛋白的表达,转基因蛋白具有抑制K562细胞生长的作用。 Objective To get the protein expression of sFh 1 by transfection and to investigate the effects of sFh-1 gene transfection on the growth of K562 cells. Methods The recombinant plasmid pcDNA3-sFh-1D4 was constructed. The recombinant plasmid pcDNA3-sFh-1D4 was transfected into the bone marrow stromal cells by Lipofectamine 2000, which was identified by RT-PCR, ELISA and MTT. Results The transfection efficiency identified by flow cytometry was 9.27%. The protein expression of sFh-1D4 was found in the culture supernatant 24 h, 48 h and 4 weeks after transfetion by ELISA and the expression concentrations were (0.104±0. 078 ), (0. 158±0. 022) and (0. 171±0. 069)μg·L^-1, respectively. The content of VEGF secreted by K562 culturing with transfectant cells culture supernatant was reduced compared with control. The inhibitoy rates on the proliferation of K562 cells via MTT assay were 9.41%±4.71%, 23.63%±7.50%, and 33.13%±6.93%, respectively. Oonclusion The bone marrow stromal cells transfected with recombinant plasmid pcDNA3-sFh-1D4 could secrete sFh-1D4 and inhibit the proliferation of K562 cells.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2008年第2期246-250,共5页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅科技发展项目资助课题(20030546)
关键词 受体 生长因子 内皮 血管 转染 骨髓基质细胞 K562细胞 receptor, growth factor endothelium, vascular transfection bone marrow stromal cells K562 cells
  • 相关文献

参考文献8

  • 1赵钧铭,褚建新,王淑萍,徐世才.转染血管内皮细胞生长因子受体基因的K562细胞在裸鼠体内生长的实验研究[J].中华血液学杂志,2001,22(5):229-231. 被引量:3
  • 2朱晶,宋艳秋,李薇,王冠军.人可溶性血管内皮生长因子受体1抑制白血病细胞增殖的研究[J].中国实验血液学杂志,2007,15(1):168-174. 被引量:3
  • 3Persano L, Crescenzi M, Indraccolo S. Anti-angiogenic gene therapy of cancer: Current status and future prospects [J]. Mol Aspects Med, 2007, 28 (1): 87-114.
  • 4Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [ J]. Blood , 2000, 96 (6):2240-2245.
  • 5Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis [J]. Angiogenesis, 2006, 9 (4): 225-230.
  • 6Malecki M, Trembacz H. Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications [J]. Oncol Rep, 2005, 14 (6): 1565-1569.
  • 7Bianco P, Riminucci M, Gronthos SI, et al. Bone marrow stromal stem cells.- nature, biology, and potential applications [J]. Stem Cells, 2001, 19 (3): 180-192.
  • 8Herley MT, Yu Y, Whitney RG, et al. Characterization of the VEGF binding site on the Flt-1 receptor [J], Bioehem BiophysRes Commun, 1999, 262 (3): 731-738.

二级参考文献9

  • 1Ferrara N. VEGF and the quest of tumor angiogenesis factor. Nat Rev Cancer, 2002 ; 2:795 - 803
  • 2Goodsell DS. The molecular perspective: VEGF and angiogenesis,Oncologist, 2002 ; 7:569 - 570
  • 3Hashimoto M, Ohsawa M, Ohnishi A, et al. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma.Lab Invest, 1995 ;73:859 - 863
  • 4Saleh M, Stacker SA, Wilks AF, Inhibition of growth C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res,1996; 56:393 -401
  • 5Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res, 1999; 59:728 -733
  • 6Kendall RL, Wang G,Thomas KA. Identification of a natural soluble vascular endothelial growth factor receptor,FLT-1 ,and its heterodimerization with KDR. Biochem Biophys Res Commun, 1996; 226:324- 328
  • 7Lin P, Sanker S, Shan SQ. Inhibition of tumor growth by targeting tumorendothelium using a soluble vascular endothelial growth factor receptor. Cell growth differ, 1998 ; 9:49 -58
  • 8刘卫霞.骨髓血管和血流的研究进展[J].国外医学(输血及血液学分册),1999,22(4):243-245. 被引量:2
  • 9糜军,王建华,陈诗书.可溶性VEGF受体基因sflt-1与反义VEGF核苷酸对新生血管形成的影响[J].癌症,2002,21(5):464-468. 被引量:10

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部